Travoprost 0.004%/Timolol 0.5% Versus Timolol 0.5% in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension
| Status: | Archived |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | January 2010 |
Eligible patients will be randomized in a 1:1 ratio to receive Travoprost 0.004% / Timolol,
once daily or Timolol 0.5%, twice-daily, for a total of twelve weeks. The study treatments
will be compared for mean intraocular pressure (IOP) change from baseline at Week 12.
Safety parameters measured at 3 study visits are : Ocular signs, visual acuity, dilated
fundus, cardiovascular parameters (blood pressure and pulse), and adverse events.
We found this trial at
1
site
Alcon Call Center Alcon is helping people see the world better through advanced surgical, pharmaceutical...
Click here to add this to my saved trials
